Our Approach To Malignant Mesothelioma

Find a Doctor Find a Clinical Trial Or Call Us: 646-929-7950

What Sets Us Apart

Malignant mesothelioma is type of cancer that affects the lining of the body’s organs and structures, known as the mesothelium. It usually affects the lining of the lungs and the chest wall, but it can also develop in the abdominal cavity and lining of the heart.

This rare cancer is usually caused by exposure to asbestos, a fiber that was once used to insulate homes, commercial buildings, and schools. When inhaled or ingested, asbestos cannot be broken down in the body. It causes permanent inflammation and, eventually, an aggressive cancer.


At NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.Find a Clinical Trial

Until recently, treatment choices were limited. Today, a world-renowned team of researchers, thoracic specialists, and oncologists at NYU Langone’s Laura and Isaac Perlmutter Cancer Center offers many options.

Treatment at NYU Langone

Treatment for malignant mesothelioma includes surgical procedures to remove the lining of organs affected by cancer. In some situations, surgeons must remove an entire organ, such as a lung. Doctors often recommend these procedures in combination with chemotherapy and radiation therapy. New targeted drugs, immunotherapies, and gene therapies are available through clinical trials.

Our Experts

More Resources

Meet Our Doctors

NYU Langone specialists provide care and support throughout your entire healthcare journey.

Browse Doctors